Pentasa in lieu of sulfasalazine.
作者信息
Mulder C J, Tytgat G N, Dekker W, Terpstra I J
出版信息
Ann Intern Med. 1988 Jun;108(6):911-2. doi: 10.7326/0003-4819-108-6-911_2.
PMID:2897181
Abstract
摘要
相似文献
1
Pentasa in lieu of sulfasalazine.
Ann Intern Med. 1988 Jun;108(6):911-2. doi: 10.7326/0003-4819-108-6-911_2.
2
[Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].[5-氨基水杨酸治疗慢性炎症性肠病]
Internist (Berl). 1987 Jan;28(1):14-20.
3
[Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
Dtsch Med Wochenschr. 1986 May 2;111(18):721-2.
4
[Salozosulphapyridine and its metabolites in ulcerative colitis and Crohn disease].[柳氮磺吡啶及其代谢产物在溃疡性结肠炎和克罗恩病中的研究]
Ugeskr Laeger. 1982 Feb 1;144(5):304-6.
5
[Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid].
Klin Wochenschr. 1988 Nov 15;66(22):1147-50. doi: 10.1007/BF01727854.
6
Sulfasalazine and new analogues.
Am J Gastroenterol. 1986 Feb;81(2):141-4.
7
Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update.口服5-氨基水杨酸制剂治疗炎症性肠病。最新进展。
Dig Dis Sci. 1987 Dec;32(12 Suppl):57S-63S. doi: 10.1007/BF01312465.
8
Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease.
J Pak Med Assoc. 1985 Mar;35(3):64-8.
9
[Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
Dtsch Med Wochenschr. 1992 Oct 16;117(42):1614-5.
10
Rolling review: inflammatory bowel disease.
Aliment Pharmacol Ther. 1993 Oct;7(5):567-79. doi: 10.1111/j.1365-2036.1993.tb00134.x.
引用本文的文献
1
Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.缓释美沙拉嗪：对其在溃疡性结肠炎和克罗恩病中的治疗潜力的综述
Drugs. 2000 Apr;59(4):929-56. doi: 10.2165/00003495-200059040-00016.
Zotero 插件